Boc-D-Aspartic Acid 4-Cyclohexyl Ester: Reliable Performance from a Manufacturer’s Perspective

Product Introduction: What Boc-D-Aspartic Acid 4-Cyclohexyl Ester Brings to the Bench

In the laboratory, nothing beats a product engineered with repeatable results in mind. Boc-D-Aspartic Acid 4-Cyclohexyl Ester (CAS Number: 102461-82-3) stands as a proven intermediate that fills a unique space in peptide synthesis and pharmaceutical development. This compound features a Boc-protected D-aspartic acid backbone esterified with cyclohexanol. From the production floor to the bench, every batch goes through a tightly controlled process, which ensures high chemical purity, limited racemization, and functional group stability—qualities every organic chemist or project lead wants for reproducibility.

Our Experience with Boc-D-Aspartic Acid 4-Cyclohexyl Ester

Making Boc-D-Asp(OCHX)-OH is a balancing act between rigorous synthetic steps and consistent isolation. Over the years, the synthetic route we optimized sidesteps the classic pitfalls: problematic byproducts, diastereomer formation, or unwanted deprotection. We use solid-phase and solution-phase peptide chemistry in our facility, so we’ve tested this material under a range of conditions. It resists premature Boc removal, tolerates a variety of coupling reagents, and consistently dissolves in polar organic solvents. We do not chase single-use shipments — our products are intended to stand up to week-long resynthesis campaigns and aging in proper storage. When handling the powder or solution, lab techs appreciate its consistent texture and manageable odor profile, critical for daily repeated use.

Specifications That Matter in the Lab

Boc-D-Aspartic Acid 4-Cyclohexyl Ester, in our production line, arrives as a white to off-white crystalline powder. Each lot receives HPLC and NMR scrutiny, and we don’t release material that falls below an assay of 98.5%. Residual solvents remain within accepted limits, and heavy metals drop below detection—every time. We monitor moisture by Karl Fischer titration, since even slight dampness in peptide intermediates can derail activation steps. Pack size starts at 25 grams for pilot work and scales up to kilograms for larger campaigns. Our warehouse stocks the product in amber bottles under inert gas so the fine powder does not clump or degrade during storage and shipping, no matter the season.

Why the Boc and Cyclohexyl Protecting Groups Matter

This molecule serves as a protected D-aspartic acid with both the α-amino group secured by a tert-butyloxycarbonyl (Boc) group and the γ-carboxyl barred by a bulky cyclohexyl ester. Here’s a real-world example: researchers have to outmaneuver byproducts and side-reactions when building a peptide with a sensitive D-amino acid in the chain. The Boc group resists cleavage by weak acids while releasing smoothly with TFA when the synthesis hits the right stage. The cyclohexyl ester, bulkier than methyl or benzyl groups, delivers extra protection during condensation steps because it proves far less prone to migration or hydrolysis. Some protecting groups, particularly the methyl or benzyl esters, give headaches during global deprotection, but the cyclohexyl ester breaks cleanly under basic or hydrogenolysis conditions. That makes downstream purification less of a struggle and keeps the final product purer for downstream testing or preclinical work.

Field Applications: Lessons Learned from Peptide Synthesis

Colleagues building small therapeutic peptides or complex drug-lead structures need solid intermediates for predictable results. For example, in solid-phase peptide synthesis (SPPS), premature loss of a protecting group can ruin an entire batch and set timelines back by weeks or months. Using Boc-D-Aspartic Acid 4-Cyclohexyl Ester, we’ve seen sharply lower side-product formation in repeated couplings onto resin. The cyclohexyl group protects against trans-esterification, particularly in protocols involving repeated washes with dichloromethane and DMF. The standard work-up never turns up unreacted starting material, and crystallization following re-acidification separates cleanly.

Customers often bring us samples from their own lines after using alternative sources. Residues and batch-to-batch variability from less rigorous manufacturing sometimes force them to repeat syntheses. Our method controls optically pure D-configuration by repeated chiral HPLC checks across all output. This matters for applications where D- versus L- enantiomerism drives peptide folding and in vivo activity.

Solving Common Peptide Chemistry Problems

Every chemist seeks intermediates that don’t fragment or carry hidden contaminants into final products. Some protecting groups, such as methyl, ethyl, or tert-butyl esters, often leave traces even after strong deprotection. We’ve run parallel experiments with Boc-D-Asp(OMe)-OH, Boc-D-Asp(OtBu)-OH, and Boc-D-Asp(OBn)-OH, and the outcome is clear: cyclohexyl esters yield faster and purer cleavage with sodium hydroxide or under hydrogenolysis compared with benzyl or tert-butyl analogs. Crude purity jumps several points higher, as confirmed by our chromatograms.

In scale-up projects, the resin gets loaded with this building block for iterative addition, and teams see fewer failed condensations. The robust protecting groups minimize side products even as scale grows beyond 100 grams per batch—critical for GMP trial runs and early-stage validation.

Differences Compared to Other Protected Aspartic Acids

Many labs default to methyl or benzyl esters for aspartic acid derivatives given their ready availability. During our own method development, methyl esters hydrolyzed too quickly in basic washes, and benzyl esters struggled during global deprotection steps, particularly during peptide chain cleavage with strong acids or palladium-catalyzed hydrogenation. Tert-butyl groups, while common, sometimes leave behind isobutylene or require multiple steps for full removal. The cyclohexyl ester provides a balance between chemical stability and selective lability. Even in environments with mild acids, it stays attached.

In head-to-head run-offs, our cyclohexyl-esterified derivative gives up fewer unwanted fragments and sidesteps contamination from over-deprotected sites. Scientists working with chiral catalysts also appreciate the minimized epimerization—a feature made possible by our reaction temperatures and purification protocols.

From Lab Bench to Production Line: What Scale Reveals

Many manufacturers make small quantities for catalog supply, never scaling up to hundreds of grams or more. Our own process can push kilogram quantities in a continuous-flow synthesis setup. Before scaling, we evaluated critical points like exotherm management, solvent recovery, and holding times for each intermediate. On repeated campaigns, we tracked product stability at each holding stage and observed no significant decomposition for months when stored dry under argon.

We know that downstream customers may need multi-kilogram supplies, sometimes with weeks of transport in variable climates, so our packaging keeps out light, moisture, and oxygen. Whether used in clinical batch peptide synthesis or exploratory SAR programs, our product maintains its performance.

Supporting Regulatory and Research Compliance

GMP compliance grows more critical as researchers move toward the clinic. Each lot we deliver is fully traceable to starting materials, with analytical data supplied from our own QC team. We check all final material for known genotoxic impurities, and provide residual solvent and heavy-metal data in each shipment. Auditors can review the production records and in-process chromatograms for assurance—no surprises, just honest results.

Over the past decade, as import regulations and testing protocols have tightened across Europe, the US, and East Asia, we revised our analytical parameters to stay ahead. Chemists do not want delays from certificate gaps or customs seizures, so our documentation anticipates questions before they arise.

Process Improvements and User Feedback

Chemistry never stands still, and the best insight often comes from research groups using these intermediates in new ways—sometimes outside peptide chemistry, such as catalyst ligands or chiral auxiliaries. We collect feedback and tweak our drying, sieving, or bottling processes when quality control teams spot improvement points. If a batch picks up more residual moisture after a hot summer shipment, we verify and correct our procedures for next time, never ignoring user experience. While purity and stereochemistry remain paramount, we’ve found ease of handling and re-solubilization matters nearly as much.

Each year brings new synthetic targets for pharmaceutical leads, and firms run pilot studies with protected D-amino acids to increase compound stability and tweak biological activity. We provide custom pack sizes and prioritize rapid response to questions about solubility, compatibility, or possible contaminants. Whenever a new literature method suggests a change, our chemists test variants side-by-side to check for real-world benefit before rolling out process modifications.

Environmental and Safety Considerations

Large-scale chemical production requires care in managing both environmental impact and workplace safety. Solvents used in the process, like dichloromethane or DMF, get recovered and recycled to minimize waste. We trained our team to handle acid chlorides and coupling agents with stringent containment and monitoring. Off-gas and solvent emissions do not leave the site without passing through activated carbon or other scrubbers, and we report each cycle’s waste handling as part of annual audits.

Finished Boc-D-Aspartic Acid 4-Cyclohexyl Ester, unlike many specialty reagents, ships safely in UN-rated packaging with full hazard data. Our logistics staff keeps up with new transport regulations to guarantee timely, legal shipment to established partners and licensed sites. As regulations shift globally, our compliance and safety teams adapt, and we pass along any handling or packaging changes to users rather than forcing surprises on delivery day. Proper handling instructions accompany every dispatch, and we encourage lab managers to reach out for advice before upscaling.

Applied Research and Case Study

One contract client tackled macrocyclic peptide synthesis targeting enzyme inhibition. Their early runs, using aspartic acid methyl ester derivatives, faced persistent problems: partial hydrolysis during coupling and unexpected deprotection during subsequent TFA cleavage. They turned to our Boc-D-Aspartic Acid 4-Cyclohexyl Ester, and the improvements followed quickly: yields rose by 15–20%, chromatograms of the crude product grew noticeably cleaner, and, most importantly, the time from bench to scale-up halved. After the initial success, they ordered kilo-quantities for regulatory scale validation, and feedback since then has focused on process robustness and final product integrity.

Another group, focusing on analog synthesis for CNS-active peptides, reported that epimerization at the D-center dropped to near-unmeasurable levels—critical when biological function depends on strict stereochemistry.

Market and Research Trends: Looking Ahead

Demand continues to rise for higher-purity, specialized D-amino acid building blocks, thanks in part to shifts toward D-peptides in both drug discovery and research applications. D-amino acids offer better resistance to proteolytic cleavage in vivo, so the stakes for stereochemical purity only grow as more pharmaceutical groups add these compounds to their pipelines.

Current literature points to further innovation with new coupling agents or even semi-automated flow chemistry setups for peptide elongation. Our development chemists monitor these trends, ready to refine old methods and try new approaches for both small batches and bulk orders. The need for stable, high-purity protecting groups will persist, and our manufacturing process remains responsive to both tradition and technical progress.

Our View: Practical Reliability in Each Shipment

With years spent making Boc-protected D-aspartic acid derivatives, we understand that both reliability and transparency matter. Research teams want clean, confidently sourced intermediates without hidden surprises. Routine batch records, open feedback loops, and an evolving process direct everything we do. Boc-D-Aspartic Acid 4-Cyclohexyl Ester stands out through its blend of physical stability, chemical performance, and ease of downstream processing—features honed over repeated real-world feedback and refinement.

Peptide chemistry stands among the most demanding sectors of fine chemical manufacturing, where mistakes lead to costly failures. A product that works well—batch after batch—offers more than convenience; it underpins project confidence and the credibility of the results that follow. From the experience of our team, this intermediate delivers that confidence, supporting scientists whether they are mapping a new drug lead or teaching peptide assembly to the next generation of chemists.